SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-068499
Filing Date
2018-11-14
Accepted
2018-11-14 17:26:31
Documents
71
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a18-19050_110q.htm 10-Q 796893
2 EX-10.1 a18-19050_1ex10d1.htm EX-10.1 34739
3 EX-10.2 a18-19050_1ex10d2.htm EX-10.2 41439
4 EX-31.1 a18-19050_1ex31d1.htm EX-31.1 12453
5 EX-31.2 a18-19050_1ex31d2.htm EX-31.2 11948
6 EX-32.1 a18-19050_1ex32d1.htm EX-32.1 5370
7 EX-32.2 a18-19050_1ex32d2.htm EX-32.2 4919
  Complete submission text file 0001104659-18-068499.txt   5894772

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT ctrv-20180930.xml EX-101.INS 1348813
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctrv-20180930.xsd EX-101.SCH 57312
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ctrv-20180930_cal.xml EX-101.CAL 34756
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ctrv-20180930_def.xml EX-101.DEF 247758
12 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ctrv-20180930_lab.xml EX-101.LAB 498471
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctrv-20180930_pre.xml EX-101.PRE 367324
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36856 | Film No.: 181185229
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1